MacroGenics(美国)

MacroGenics

美国MacroGenicswww.macrogenics.com MACROGENICS是美国的生物技术制药公司，拥有癌症以及炎症性疾病的抗体治疗多个技术平台,其中4个创新药物已经进入临床研究，并已与美国的辉瑞（Pfizer），德国的勃林格殷格翰（Boehringer-Ingelheim）等国际企业建立了长期合作的关系。Sinceitsfoundingin2000,MacroGenicshasfo cusedonapplyingitsworld-classantibodycapabilitiestodiscover,developanddelivertopatientsnovelbiologicsforthetreatmentofcancer,autoimmunedisordersandinfectiousdiseases.Ourteamof135dedicatedindividualsiscommittedtoapplybreakthroughsciencetocreatelife-changingmedicines.Asanexample,ourleadautoimmuneproductcandidate,teplizumab,isthoughttoreprogramtheimmunesystemtore-establishthelostimmunebalancethatoccursinautoimmunediseasessuchastype1diabetes.Ifsuccessful,thisapproachwouldrepresentaparadigmshiftinthemanagementofadiseaseforwhichtherehasbeennonewtreatmentsincetheintroductionofinsulininthe1920’s.Ourinnovativeproductcandidatesl